Newsroom

Sorted by: Latest

-

2026 FoodMinds Study: Food Processing, Ingredients and Affordability Influence Consumer Choices

CHICAGO--(BUSINESS WIRE)--New FoodMinds research examines how food processing, ingredients and affordability shape consumer purchasing decisions and trust in food companies....
-

Fortune Media and Great Place To Work Name CityVet to 2026 Best Workplaces in Health Care List

DALLAS--(BUSINESS WIRE)--CityVet, a community of veterinarian-owned practices, has been named to the 2026 Fortune Best Workplaces in Health Care™ List, in the Small and Medium category. Selected by Great Place To Work® and Fortune magazine, the recognition marks CityVet's second consecutive year on the prestigious list and distinguishes the company as the only general practice veterinary company recognized among the nation's leading health care employers. Founded in Dallas in 1999, CityVet has...
-

Wolters Kluwer expands agentic tax and audit capabilities in CCH Axcess

MINNEAPOLIS--(BUSINESS WIRE)--Wolters Kluwer Tax & Accounting today unveiled new agentic capabilities for tax planning, fixed asset, and audit capabilities in CCH Axcess™ at CCH Connections 2026 in Orlando, reinforcing the platform as the place where tax and audit work gets done. With recently announced agentic tax preparation, work can move in one platform from client documents to a prepared return, from the return to a planning recommendation, and from engagement documents to audit planni...
-

MotorK Goes From Zero to More Than 25% of Its Customer Base Using Spark AI Agents in One Quarter

LONDON--(BUSINESS WIRE)--Regulatory News: MotorK PLC (AMS: MTRK) ("MotorK", the "Group" or the "Company"), a leading SaaS provider to the automotive retail industry in the EMEA region, today announced its financial results for the nine months ended 30 September 2026 ("Q3 26"). Q3 26 KEY FINANCIAL HIGHLIGHTS Committed Annual Recurring Revenue (CARR1): €32.4 million at 30 September 2026, down 10% from €36.0 million a year earlier, mainly reflecting the exit of legacy and non-core contracts. Annua...
-

Samenvatting: Actiphy kondigt ImageServer aan voor gecentraliseerde back-upopslag en post-back-upverwerking

WILDOMAR, Calif.--(BUSINESS WIRE)--Actiphy™, Inc., een aanbieder van software voor back-up, disaster recovery en virtualisatie, kondigde vandaag Actiphy ImageServer™ aan, een gecentraliseerd platform voor het opslaan, beheren, verifiëren en repliceren van back-ups aangemaakt met ActiveImage Protector™. ImageServer combineert de beheerscapaciteiten van Actiphy ImageCenter™ met de veilige opslag van Actiphy StorageServer™. Door Verify, Replication, Consolidation, en BootCheck™ naar een specifieke...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  26-October-2026 Issue: Mitsubishi HC Capital UK Plc Series 824 XS2671728892 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 29-July-2026 Date To: 29-October-2026 Record Date: 28-October-2026 Value Date: 29-October-2026 Benchmark Rate: 3.74854% Margin: 1.24% Total Rate: 4.98854% Number of Days: 92 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: USD 382,45...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  26-October-2026 Issue: Bank of Montréal Series 442 XS3218066788 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 28-October-2026 Date To: 28-January-2027 Record Date: 27-January-2027 Value Date: 28-January-2027 Benchmark Rate: 2.638% Margin: 0.65% Total Rate: 3.288% Floor: 0% Number of Days: 92 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: EUR 8,402,666...
-

Resumen: Incyte destaca nuevos datos que hacen avanzar su cartera para el cáncer gastrointestinal en ESMO 2026

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) anunció hoy nuevos resultados de su cartera oncológica en permanente desarrollo, incluida una actualización de los resultados de su inhibidor de KRAS G12D (INCB161734) en adenocarcinoma ductal pancreático (PDAC) y cáncer colorrectal (CRC) avanzado o metastásico, y su anticuerpo biespecífico contra TGFβR2×PD-1 (INCA338901) en cáncer colorrectal con estabilidad de microsatélites (MSS CRC). El comunicado en el idioma original es la versi...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  26-October-2026 Issue: Coventry Building Society, CB Series 5 XS2498152920 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 01-October-2026 Date To: 02-November-2026 Record Date: 30-October-2026 Value Date: 02-November-2026 Benchmark Rate: 3.7384% Margin: 0.53% Total Rate: 4.2684% Floor: 0% Number of Days: 32 Day Count: Actual / 365 (Fixed) Interest Frequency: Monthly Total Amou...
-

Riassunto: Agendia presenta la convalida clinica di un approccio alla patologia digitale basato sull'AI

IRVINE, California, e AMSTERDAM--(BUSINESS WIRE)--Agendia, Inc., leader nell'oncologia di precisione per il tumore al seno, di recente ha illustrato una ricerca che presenta l'approccio sperimentale alla patologia digitale dell'azienda, basato sull'IA, per la firma delle recidive MammaPrint ® a 70 geni in occasione del Congresso mondiale 2026 della European Society for Medical Oncology (ESMO) a Madrid. La presentazione orale, a cura della co-fondatrice e responsabile della ricerca Laura van 't...